Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?

@article{Senti2011EpicutaneousAA,
  title={Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?},
  author={Gabriela Senti and S von Moos and Thomas M. K{\"u}ndig},
  journal={Allergy},
  year={2011},
  volume={66 6},
  pages={798-809}
}
IgE-mediated allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, today affecting up to 30% of the population in industrialized countries. Allergen-specific immunotherapy (SIT) either subcutaneously or via the sublingual route is effective, but only few patients (<5%) choose immunotherapy, as treatment takes several… CONTINUE READING